MYOM2 and Miyoshi myopathy: A retrospective study conducted in China by Qin et al. on newly diagnosed MM cases treated with either bortezomib-based or thalidomide-based therapy analyzed MM with unmeasurable M protein (categorized as 61 OSMM, 19 NSMM, and 7 non-producer MM cases).